Press release
Investigation over potential Wrongdoing announced for Investors who lost money with shares of DermTech, Inc. (NASDAQ: DMTK)
An investigation on behalf of investors in DermTech, Inc. (NASDAQ: DMTK) shares over possible breaches of fiduciary duty.
Investors who are current long term investors in DermTech, Inc. (NASDAQ: DMTK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: DMTK stocks follows a lawsuit filed against DermTech, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: DMTK stocks, concerns whether certain DermTech, Inc. directors are liable in connection with the allegations made in that lawsuit.
According to that complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges that, the Defendants failed to disclose to investors that the Company experienced challenges with collections from commercial payors, that, as a result, there was a lower average selling price for DermTech's DMT, that, as a result of the foregoing, the Company's revenue growth would be adversely impacted, and that , as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Those who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation over potential Wrongdoing announced for Investors who lost money with shares of DermTech, Inc. (NASDAQ: DMTK) here
News-ID: 3542115 • Views: …
More Releases from Shareholders Foundation, Inc.
Lawsuit filed for Investors who lost money with shares of Primo Brands Corporati …
An investor, who purchased shares of Primo Brands Corporation (NYSE: PRMB), filed a lawsuit over alleged violations of Federal Securities Laws in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of Primo Water (formerly NYSE: PRMW) between June 17, 2024 through November 8, 2024, and/or purchased a significant amount of shares Primo Brands Corporation (NYSE: PRMB) between November 11, 2024 through November 6,…
Lawsuit Alert: Investors who lost a substantial amount with Telix Pharmaceutical …
An investor, who purchased shares of Telix Pharmaceuticals Limited (NASDAQ: TLX), filed a lawsuit in the U.S. over alleged violations of Federal Securities Laws by Telix Pharmaceuticals Limited in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Telix Pharmaceuticals Limited (NASDAQ: TLX) have certain options and for certain investors are short and strict deadlines running. Deadline: January 9, 2026. NASDAQ: TLX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in shares of Savara Inc. (NASDAQ …
An investigation was announced for long-term investors in shares of Savara Inc. (NASDAQ: SVRA) concerning potential breaches of fiduciary duties by certain directors of Savara Inc.
Investors who are current long term investors in Savara Inc. (NASDAQ: SVRA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: SVRA stocks…
Lawsuit filed for Investors who lost money with shares of Inspire Medical System …
An investor, who purchased shares of Inspire Medical Systems, Inc. (NYSE: INSP), filed a lawsuit over alleged violations of Federal Securities Laws by Inspire Medical Systems, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Inspire Medical Systems, Inc. (NYSE: INSP) have certain options and for certain investors are short and strict deadlines running. Deadline: January 5, 2026. NYSE: INSP investors should contact the Shareholders…
More Releases for DermTech
U.S. Diagnostic Dermatology Equipment Market to Reach USD 3.06 Billion by 2030, …
The U.S. Diagnostic Dermatology Equipment Market was valued at US$ 1.84 billion in 2024 and is projected to reach US$ 3.06 billion by 2030, growing at a CAGR of 9% during the forecast period.
The market maintains a strong position in the U.S. healthcare landscape, driven by the rising prevalence of skin cancers, chronic skin conditions, and increasing demand for early and accurate diagnosis. Growth is supported by continuous advancements in…
AI Skin Analysis Market - Massive Growth Opportunity Seen Ahead | SkinVision, De …
HTF MI just released the Global AI Skin Analysis Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major Giants in AI Skin Analysis Market are:
IBM Watson Health…
Deadline on Dec. 15th coming up in Lawsuit for Investors in DermTech, Inc. (NASD …
A deadline is coming up on December 15, 2023 in the lawsuit filed for certain investors of DermTech, Inc. (NASDAQ: DMTK) over alleged securities laws violations by DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and there are strict and short deadlines running. Deadline: December 15, 2023. NASDAQ: DMTK stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Lawsuit filed for certain Investors who lost money with shares of DermTech, Inc. …
An investor, who purchased shares of DermTech, Inc. (NASDAQ: DMTK), filed a lawsuit over alleged violations of Federal Securities Laws by DermTech, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 2022, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2023. NASDAQ:…
Investigation announced for Investors in shares of DermTech, Inc. (NASDAQ: DMTK) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain DermTech directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Diego, CA based DermTech,…
Investigation announced for Investors who lost money with shares of DermTech, In …
An investigation was announced for investors of DermTech, Inc. (NASDAQ: DMTK) shares over potential securities laws violations by DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of DermTech, Inc. (NASDAQ: DMTK) concerning whether a series…
